Remdesivir Intermediate CAS 1770840-43-1 4-Amino-7-iodopyrrolo[2,1-f][1,2,4]triazine COVID-19
Produsen Pasokan Komersial Remdesivir lan Intermediet sing Gegandhengan kanthi Kualitas Tinggi
Remdesivir CAS 1809249-37-3
2-Etil-1-butanol CAS 97-95-0
Trimetilsilil Sianida CAS 7677-24-9
4-Nitrophenol CAS 100-02-7
2-Etilbutil ((S)-(perfluorofenoksi)(fenoksi)fosforil)-L-alaninate CAS 1911578-98-7
N-[(S)-(4-nitrophenoxy)phenoxyphosphinyl]-L-Alanine 2-etilbutil ester CAS 1354823-36-1
(S)-2-Etilbutil 2-Aminopropanoate Hydrochloride CAS 946511-97-3
Metabolit Remdesivir (GS-441524) CAS 1191237-69-0
Remdesivir N-2 Intermediate CAS 1191237-80-5
2,3,5-Tri-O-benzyl-D-ribonolactone CAS 55094-52-5
7-Bromopyrrolo[2,1-f][1,2,4]triazin-4-amin CAS 937046-98-5
Pyrrolo[1,2-F][1,2,4]Triazin-4-Amine CAS 159326-68-8
4-Amino-7-iodopyrrolo[2,1-f][1,2,4]triazine CAS 1770840-43-1
Jeneng Kimia | 4-Amino-7-iodopyrrolo[2,1-f][1,2,4]triazine |
sinonim | 7-Iodopyrrolo [2,1-f] [1,2,4] triazin-4-amin;Remdesivir-004;Remdesivir Impurity 30 |
Nomer CAS | 1770840-43-1 |
Nomer CAT | RF-PI304 |
Status Simpenan | Ing Stok, Skala Produksi Nganti Atusan Kilogram |
Formula Molekul | C6H5IN4 |
Bobot Molekul | 260.04 |
Merk | Kimia Ruifu |
Item | Spesifikasi |
Penampilan | Cahya kuning nganti coklat bubuk |
Spektrum Infrared | Conforms kanggo Struktur |
Kemurnian | ≥98,0% (HPLC) |
Mundhut ing Pangatusan | ≤0,50% |
Impurity Tunggal | ≤0,50% |
Logam abot | ≤20ppm |
Test Standar | Standar Perusahaan |
Panggunaan | Perantara Remdesivir (CAS 1809249-37-3) |
Paket: Botol, tas Aluminium foil, Drum karton, 25kg / Drum, utawa miturut kabutuhan pelanggan.
Kondisi panyimpenan:Simpen ing wadhah sing disegel ing papan sing adhem lan garing;Nglindhungi saka cahya, kelembapan lan infestasi hama.
4-Amino-7-iodopyrrolo [2,1-f][1,2,4] triazine (CAS 1770840-43-1) minangka Intermediate Remdesivir (CAS 1809249-37-3).Remdesivir minangka senyawa antivirus sing digunakake kanggo nyegah tumindak RNA polimerase.Remdesivir wiwitane diselidiki minangka perawatan kanggo virus Ebola, nanging duweni potensi kanggo nambani macem-macem virus RNA.Aktivitase nglawan kulawarga virus coronavirus (CoV), kayata SARS-CoV lan MERS-CoV, diterangake ing taun 2017, lan uga diselidiki minangka perawatan potensial kanggo infeksi SARS-CoV-2.